Human von Willebrand factor (Boya Bio-Pharmaceutical)

人血管性血友病因子（博雅生物）

Report date: 2022/12/09 20:00:56

Base Information

Drug NameHuman von Willebrand factor (Boya Bio-Pharmaceutical)
Drug Alias NameVWF productvon Willebrand Factor productVWF
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII stimulantsVon willebrand factor replacementsBlood coagulation pathway activation
TargetsCoagulation factor VIII
Therapy Area/Indicationsvon Willebrand Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBoya Bio-Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoya Bio-Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active Indicationsvon Willebrand Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A